-Kafila.org Over 115 women have signed a letter seeking an apology from Ms. Meenakshi Lekhi for her sexist slandering of deceased Ishrat Jahan in a television channel. The letter has also been sent to the Chairperson of the National Commission for Women for appropriate action. As the noose is tightening around the conspirators who cynically and coldly planned and executed the killing of teenaged Ishrat Jahan and three other people in 2004,...

-The Hindu New Delhi should stop its flip-flops and adopt a coherent policy in its negotiations on greenhouse gas emissions If the great Scott Fitzgerald were to have walked into the grand plenary hall of the Durban climate conference in 2011 to announce once again, "show me a hero and I will write you a tragedy," all fingers would have pointed to the tiny Indian contingent in the room. There, Fitzgerald would...

-The Economic Times The World Trade Organisation (WTO) has honoured renowned economist and globalisation buff Jagdish N Bhagwati by inducting him into its Hall of Fame. The professor of economics and law at Columbia University, Bhagwati is the author of books as seminal as 'In Defence of Globalisation' and 'The Wind of the Hundred Days: How Washington Mismanaged Globalisation'. He spoke to ET about his decades-long campaign for trade liberalisation, his...

-PTI Pingali has been appointed director of the Tata-Cornell Initiative in Agriculture and Nutrition Washington: Former World Bank economist Prabhu Pingali has been appointed by the Cornell University to lead effort to help reduce poverty and malnutrition in India, a project established through a USD 25 million endowment from the Tata Trusts. Pingali has been appointed director of the Tata-Cornell Initiative in Agriculture and Nutrition (TACO-AN), a long-term project established through a...

-The Economic Times WASHINGTON: Big Pharma found little support from the small guy on the street as the Indian Supreme Court's decision to reject patent claims of the drug maker Novartis for its celebrated cancer medicine Glivec reverberated across the world. The pharma lobby railed against the decision but the overwhelming sentiment, from physicians to politicians, from academia to media, particularly in a country groaning from the high cost of health care,...